Intra-Cellular Therapies
ITCI
#1798
Rank
NZ$15.30 B
Marketcap
$144.33
Share price
-0.28%
Change (1 day)
57.40%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.69. In 2022 the company made an earnings per share (EPS) of -$4.55 an increase over its 2021 EPS that were of -$5.85.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-42.82%
2022-$4.55-22.29%
2021-$5.858.02%
2020-$5.4220.9%
2019-$4.48-5.63%
2018-$4.7533.96%
2017-$3.55-21.19%
2016-$4.50-7.56%
2015-$4.87174.53%
2014-$1.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.42-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.72 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.58 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA